(PDF) Molecular Basis of Hemophilia B: Identification of

Molecular Basis of Hemophilia B: Identification of the Defect in Factor Ix Vancouver

doi 10.1055/s-0038-1643872

Full Text

Open PDF

Abstract

Available in full text

Date

January 1, 1987

Authors

Publisher

Schattauer GmbH

Related search

Identification of the Molecular Defect in Factor IX Chapel Hill: Substitution of Histidine for Arginine at Position 145.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1983

English

Survey of the Anti-Factor IX Immunoglobulin Profiles in Patients With Hemophilia B Using a Fluorescence-Based Immunoassay

Journal of Thrombosis and Haemostasis

Medicine

Hematology

2016

English

Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients

Biochemistry

2015

English

Three Point Mutations in the Factor IX Genes of Five Hemophilia B Patients. Identification Strategy Using Localization by Altered Epitopes in Their Hemophilic Proteins.

Journal of Clinical Investigation

Medicine

1989

English

Oral Delivery of Bioencapsulated Coagulation Factor IX Prevents Inhibitor Formation and Fatal Anaphylaxis in Hemophilia B Mice

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2010

English

Hemophilia as a Defect of the Tissue Factor Pathway of Blood Coagulation: Effect of Factors VIII and IX on Factor X Activation in a Continuous-Flow Reactor.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1990

English

Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B

Journal of Translational Medicine

English

Structural and Functional Basis of the Developmental Regulation of Human Coagulation Factor IX Gene: Factor IX Leyden.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1990

English

Engineered Factor VII, Factor IX, and Factor X Variants for Hemophilia Gene Therapy

Journal of Genetic Syndromes & Gene Therapy

2012

English

Amanote Research

Molecular Basis of Hemophilia B: Identification of the Defect in Factor Ix Vancouver

doi 10.1055/s-0038-1643872

Full Text

Abstract

Date

Authors

Publisher

Related search

Identification of the Molecular Defect in Factor IX Chapel Hill: Substitution of Histidine for Arginine at Position 145.

Survey of the Anti-Factor IX Immunoglobulin Profiles in Patients With Hemophilia B Using a Fluorescence-Based Immunoassay

Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients

Three Point Mutations in the Factor IX Genes of Five Hemophilia B Patients. Identification Strategy Using Localization by Altered Epitopes in Their Hemophilic Proteins.

Oral Delivery of Bioencapsulated Coagulation Factor IX Prevents Inhibitor Formation and Fatal Anaphylaxis in Hemophilia B Mice

Hemophilia as a Defect of the Tissue Factor Pathway of Blood Coagulation: Effect of Factors VIII and IX on Factor X Activation in a Continuous-Flow Reactor.

Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B

Structural and Functional Basis of the Developmental Regulation of Human Coagulation Factor IX Gene: Factor IX Leyden.

Engineered Factor VII, Factor IX, and Factor X Variants for Hemophilia Gene Therapy